{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:48:20Z","timestamp":1791557300984,"version":"4.3.4"},"reference-count":53,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T00:00:00Z","timestamp":1690675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Proyecto de I+D+I en salud-ISCIII 2022 de la Acci\u00f3n Estrat\u00e9gica en Salud Intramural (AESI)","doi-asserted-by":"publisher","award":["PI22CIII\/00053"],"award-info":[{"award-number":["PI22CIII\/00053"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive aspergillosis (IA) is a major cause of morbidity and mortality in patients receiving allogeneic haematopoieticcell transplantation. The deep immunosuppression and a variety of potential additional complications developed in these patients result in IA reaching mortality rates of around 50\u201360%. This mortality is even higher when the patients are infected with azole-resistant isolates, demonstrating that, despite the complexity of management, adequate azole treatment can have a beneficial effect. It is therefore paramount to understand the reasons why antifungal treatment of IA infections caused by azole-susceptible isolates is often unsuccessful. In this respect, there are already various factors known to be important for treatment efficacy, for instance the drug concentrations achieved in the blood, which are thus often monitored. We hypothesize that antifungal persistence may be another important factor to consider. In this study we present two case reports of haematological patients who developed proven IA and suffered treatment failure, despite having been infected with susceptible isolates, receiving correct antifungal treatment and reaching therapeutic levels of the azole. Microbiological analysis of the recovered infective isolates showed that the patients were infected with multiple strains, several of which were persisters to voriconazole and\/or isavuconazole. Therefore, we propose that azole persistence may have contributed to therapeutic failure in these patients and that this phenomenon should be considered in future studies.<\/jats:p>","DOI":"10.3390\/jof9080805","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T03:30:02Z","timestamp":1690774202000},"page":"805","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Potential Implication of Azole Persistence in the Treatment Failure of Two Haematological Patients Infected with Aspergillus fumigatus"],"prefix":"10.3390","volume":"9","author":[{"given":"Teresa","family":"Pel\u00e1ez-Garc\u00eda de la Rasilla","sequence":"first","affiliation":[{"name":"Microbiology Department, Central University Hospital of Asturias (HUCA), 33011 Oviedo, Asturias, Spain"},{"name":"Institute for Health Research in the Principality of Asturias, Instituto de Investigaci\u00f3n Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Asturias, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0212-9472","authenticated-orcid":false,"given":"\u00c1lvaro","family":"Mato-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory (Laboratorio de Referencia e Investigaci\u00f3n en Micolog\u00eda LRIM), National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara E.","family":"Pablos-Puertas","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory (Laboratorio de Referencia e Investigaci\u00f3n en Micolog\u00eda LRIM), National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Julia","family":"Gonz\u00e1lez-Huerta","sequence":"additional","affiliation":[{"name":"Hematology-Stem Cell Transplantation Unit, Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Asturias, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"G\u00f3mez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory (Laboratorio de Referencia e Investigaci\u00f3n en Micolog\u00eda LRIM), National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain"},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC-CB21\/13\/00105), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-0260","authenticated-orcid":false,"given":"Emilia","family":"Mellado","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory (Laboratorio de Referencia e Investigaci\u00f3n en Micolog\u00eda LRIM), National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain"},{"name":"CIBER de Enfermedades Infecciosas (CIBERINFEC-CB21\/13\/00105), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Amich","sequence":"additional","affiliation":[{"name":"Mycology Reference Laboratory (Laboratorio de Referencia e Investigaci\u00f3n en Micolog\u00eda LRIM), National Centre for Microbiology, Instituto de Salud Carlos III (ISCIII), 28220 Majadahonda, Madrid, Spain"},{"name":"Manchester Fungal Infection Group (MFIG), Division of Evolution, Infection, and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M139NT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e00140-18","DOI":"10.1128\/CMR.00140-18","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Chamilos","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJMra2027424","article-title":"Aspergillus Infections","volume":"385","author":"Thompson","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Baddley, J.W., Stephens, J.M., Ji, X., Gao, X., Schlamm, H.T., and Tarallo, M. (2013). Aspergillosis in Intensive Care Unit (ICU) patients: Epidemiology and economic outcomes. BMC Infect. Dis., 13.","DOI":"10.1186\/1471-2334-13-29"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Garc\u00eda, P., Alonso-Sard\u00f3n, M., Rodr\u00edguez-Alonso, B., Almeida, H., Romero-Alegr\u00eda, \u00c1., Vega-Rodr\u00edguez, V.-J., L\u00f3pez-Bern\u00fas, A., Mu\u00f1oz-Bellido, J.L., Muro, A., and Pardo-Lled\u00edas, J. (2022). How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?. J. Fungi, 8.","DOI":"10.3390\/jof8060576"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sun, K.-S., Tsai, C.-F., Chen, S.C.-C., and Huang, W.-C. (2017). Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186422"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/cncr.23441","article-title":"Changes in causes of death over time after treatment for invasive aspergillosis","volume":"112","author":"Wingard","year":"2008","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jinf.2018.02.012","article-title":"The burden of Invasive Aspergillosis in patients with haematological malignancy: A meta-analysis and systematic review","volume":"76","author":"Visser","year":"2018","journal-title":"J. Infect."},{"key":"ref_9","first-page":"20499361211039050","article-title":"Fungal infections in hematopoietic stem-cell transplant patients: A review of epidemiology, diagnosis, and management","volume":"8","author":"Rahi","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/510592","article-title":"Invasive Aspergillosis following Hematopoietic Cell Transplantation: Outcomes and Prognostic Factors Associated with Mortality","volume":"44","author":"Upton","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3324\/haematol.2011.044636","article-title":"Invasive aspergillosis in patients with hematologic malignancies: Incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009","volume":"96","author":"Nicolle","year":"2011","journal-title":"Haematologica"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","author":"Verweij","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aap7999","article-title":"Worldwide emergence of resistance to antifungal drugs challenges human health and food security","volume":"360","author":"Fisher","year":"2018","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in Aspergillus fumigatus, The Netherlands, 2007\u20132009","volume":"17","author":"Snelders","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"571.e1","DOI":"10.1016\/j.cmi.2016.01.017","article-title":"EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents","volume":"22","author":"Arendrup","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_17","unstructured":"CLSI Document M38-A2, and Wayne, P. (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Clinical and Laboratory Institute. [Approved Standard\u20142nd ed.]."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes","volume":"46","author":"Pascual","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/imj.15587","article-title":"Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021","volume":"51","author":"Chau","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1997.15.1.139","article-title":"Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery","volume":"15","author":"Caillot","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3904\/kjim.2017.109","article-title":"Voriconazole-refractory invasive aspergillosis","volume":"32","author":"Park","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e00524-19","DOI":"10.1128\/AAC.00524-19","article-title":"Tissue Distribution and Penetration of Isavuconazole at the Site of Infection in Experimental Invasive Aspergillosis in Mice with Underlying Chronic Granulomatous Disease","volume":"63","author":"Lee","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/mmy\/myy067","article-title":"Beyond tissue concentrations: Antifungal penetration at the site of infection","volume":"57","author":"Zhao","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/14787210.2016.1194754","article-title":"Should we develop screens for multi-drug antibiotic tolerance?","volume":"14","author":"Bergh","year":"2016","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","article-title":"Persistent bacterial infections and persister cells","volume":"15","author":"Fisher","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/femsre\/fux001","article-title":"Formation, physiology, ecology, evolution and clinical importance of bacterial persisters","volume":"41","author":"Fauvart","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/myc.13191","article-title":"Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection","volume":"64","author":"Levinson","year":"2020","journal-title":"Mycoses"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-04926-x","article-title":"Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia","volume":"9","author":"Rosenberg","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e0477022","DOI":"10.1128\/spectrum.04770-22","article-title":"Aspergillus fumigatus Can Display Persistence to the Fungicidal Drug Voriconazole","volume":"11","author":"Scott","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/AAC.00942-07","article-title":"Aspergillus Section Fumigati: Antifungal Susceptibility Patterns and Sequence-Based Identification","volume":"52","author":"Mellado","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Guinea, J. (2020). Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory. J. Fungi, 6.","DOI":"10.3390\/jof6040343"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations","volume":"51","author":"Mellado","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3389\/fmicb.2018.01626","article-title":"Comparison of Two Highly Discriminatory Typing Methods to Analyze Aspergillus fumigatus Azole Resistance","volume":"9","author":"Escribano","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.diagmicrobio.2018.04.003","article-title":"Simultaneous quantification of systemic azoles and their major metabolites in human serum by HPLC\/PDA: Role of azole metabolic rate","volume":"92","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"509.e1","DOI":"10.1016\/j.jtct.2022.05.008","article-title":"Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation","volume":"28","author":"Young","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.cmi.2020.05.037","article-title":"Antifungal therapeutic drug monitoring: Focus on drugs without a clear recommendation","volume":"26","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/FTD.0000000000000952","article-title":"Antifungal Drugs TDM: Trends and Update","volume":"44","author":"Kably","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12281-023-00459-z","article-title":"Invasive Aspergillosis and the Impact of Azole-resistance","volume":"17","author":"Bosetti","year":"2023","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/13693780802380537","article-title":"Characterization of multiple isolates of Aspergillus fumigatus from patients: Genotype, mating type and invasiveness","volume":"47","author":"Garcia","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"van der Torre, M.H., Shen, H., Rautemaa-Richardson, R., Richardson, M.D., and Novak-Frazer, L. (2021). Molecular Epidemiology of Aspergillus fumigatus in Chronic Pulmonary Aspergillosis Patients. J. Fungi, 7.","DOI":"10.3390\/jof7020152"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1128\/JCM.02423-06","article-title":"Comparison of Two Highly Discriminatory Molecular Fingerprinting Assays for Analysis of Multiple Aspergillus fumigatus Isolates from Patients with Invasive Aspergillosis","volume":"45","author":"Meis","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e0064221","DOI":"10.1128\/AAC.00642-21","article-title":"Multiresistance to Nonazole Fungicides in Aspergillus fumigatus TR34\/L98H Azole-Resistant Isolates","volume":"65","author":"Monzon","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-022-01091-2","article-title":"Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment","volume":"7","author":"Rhodes","year":"2022","journal-title":"Nat. Microbiol."},{"key":"ref_47","unstructured":"Melchio, M., Mikulska, M., Nadir, U., Giacobbe, D.R., Magnasco, L., Limongelli, A., Sepulcri, C., Dentone, C., Portunato, F., and Balletto, E. Lower blood levels of isavuconazole in critically ill patients compared to other populations: Possible need for TDM. Abstract O0217. ECCMID Copenhagen 15\u201318 April 2023. ECCMID eLibrary."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: Vancomycin and linezolid","volume":"26","author":"Stein","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11592900-000000000-00000","article-title":"Penetration of Anti-Infective Agents into PulmonaryEpithelial Lining Fluid","volume":"50","author":"Rodvold","year":"2011","journal-title":"Clin. Pharmacokinet."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/jac\/dkg434","article-title":"Treatment failure in invasive aspergillosis: Susceptibility of deep tissue isolates following treatment with amphotericin B","volume":"52","author":"Paterson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e01292-17","DOI":"10.1128\/AAC.01292-17","article-title":"Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats","volume":"61","author":"Kato","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.cmi.2021.02.021","article-title":"Factors associated with coinfections in invasive aspergillosis: A retrospective cohort study","volume":"27","author":"Danion","year":"2021","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/8\/805\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:22:31Z","timestamp":1760127751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/9\/8\/805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,30]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["jof9080805"],"URL":"https:\/\/doi.org\/10.3390\/jof9080805","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,30]]}}}